Galderma Prices Shares at Top End, Boosting Europe IPO Market

March 21, 2024, 6:48 AM UTC

Skincare company Galderma Group AG priced its 2.3 billion Swiss-franc ($2.6 billion) initial public offering at the top of the marketed range giving much needed confidence to a slowly rebounding market for European listings.

The EQT AB-backed company priced its IPO shares at 53 francs each, compared with a marketing range of 49 to 53 francs apiece. The stock is set to start trading Friday.

This strong appetite is being seen as a sign investors are returning to the European IPO market after shunning it for the past 18 months, mainly due to weak returns from new listings. German ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.